Key result
High cumulative LDL-C is linked to increased ESRD risk in patients with type 2 diabetes.
Why the study?
Do high cumulative LDL-C levels increase the risk of end-stage renal disease in Korean patients with type 2 diabetes?
Do high cumulative LDL-C levels increase the risk of end-stage renal disease in Korean patients with type 2 diabetes?
High cumulative LDL-C levels are associated with an increased risk of ESRD in Korean patients with type 2 diabetes, particularly those with more advanced disease.
ESRD risk increased with high cumulative LDL-C levels. This difference was more pronounced in patients with diabetes taking multiple antidiabetic medications and in those with a longer duration of diabetes.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2026) studied this question. High cumulative LDL-C levels increased end-stage renal disease risk in patients with type 2 diabetes, particularly those with longer disease duration or taking multiple antidiabetic medications.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: